CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) Deferred Taxes (2018 - 2019)

Updated

CytoDyn (CYDY) reported Deferred Taxes of -$81.00 for fiscal Q4 2019 (quarter ended May 31, 2019).

Analysis

CytoDyn (CYDY) Deferred Taxes (2018 - 2019) Analysis & Trends

For FY2019 (ended May 31, 2019), CytoDyn posted Deferred Taxes of -$2.83 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.79 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -56.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 202.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -860.00 Mn
10 CytoDyn 334.50 Mn 285.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2019 -81.00
Nov 30, 2018 2.83 Mn
API Access

CytoDyn Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=CYDY&period=max&api_key=YOUR_API_KEY